default author photo

Amanda Newman

Duke University - Department of Surgery

Duke University - Duke Human Vaccine Institute

Durham, NC 27710

United States

SCHOLARLY PAPERS

2

DOWNLOADS

85

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

HIV-1 Germline-Targeting Vaccine Regimen Selects for Rare Immunoglobulin Insertions and Deletions Typical of VRC01-Class Antibodies

Number of pages: 49 Posted: 21 Sep 2022
University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Applied Biomedical Science Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Applied Biomedical Science Institute, University of Amsterdam - Department of Medical Microbiology, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Cornell University - Department of Microbiology and Immunology, Applied Biomedical Science Institute, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, Cornell University - Department of Microbiology and Immunology, Cornell University - Department of Microbiology and Immunology, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Duke University - Duke Human Vaccine Institute, Applied Biomedical Science Institute and University of Amsterdam - Department of Medical Microbiology
Downloads 46 (1,109,210)

Abstract:

Loading...

HIV-1 Env, vaccines, germline-targeting, insertions, deletions, neutralizing antibodies, bNAbs, mouse model, NGS

2.

Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine

Number of pages: 59 Posted: 18 Feb 2022
Duke University - Duke Human Vaccine Institute, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Duke University - Duke Human Vaccine Institute, Beth Israel Deaconess Medical Center, University of Pennsylvania - Department of Microbiology, University of Pennsylvania - Department of Microbiology, Corporate Research Materials Lab, 3M Company, Infectious Disease Research Institute, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, BIOQUAL, BIOQUAL, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Government of the United States of America - Vaccine Research Center, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute
Downloads 39 (1,196,171)

Abstract:

Loading...